Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(417)
•••
Post by toade1313on Jul 03, 2019 7:30am
109 Views
Post# 29882309

Too Bad No Video of Q&A at AGM

Too Bad No Video of Q&A at AGMThe prerecorded videos were nices but for longtime shareholders not alot of new info. The true highlights of the AGM were the 'after videos' Q&A sessions. Many thanks to those that gave us feedback. Sure wish there was a video of all the questions and answers. 

Other thoughts running through my mind. 1. Why hasn't there been some feedback on the 10 presentations this week and how many actually are about Theralase? 2. How can it be so difficult to get patients treated in our ph2? 3. Do we have to complete the PP before we treat any patients in ph2?

And regards to 'Dog Day's- cancer progression doesn't take a 2 month summer holiday. Potential patients don't say 'I'm taking a 2 month vacation, I'll deal with my cancer after Labor Day'. 
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities